13-52065452-T-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_199289.3(NEK5):c.2082A>T(p.Glu694Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000129 in 1,614,164 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_199289.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NEK5 | NM_001365552.1 | c.1975+32A>T | intron_variant | ENST00000684899.1 | NP_001352481.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NEK5 | ENST00000684899.1 | c.1975+32A>T | intron_variant | NM_001365552.1 | ENSP00000509632.1 |
Frequencies
GnomAD3 genomes AF: 0.0000657 AC: 10AN: 152230Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000207 AC: 52AN: 251494Hom.: 0 AF XY: 0.000228 AC XY: 31AN XY: 135920
GnomAD4 exome AF: 0.000135 AC: 198AN: 1461816Hom.: 0 Cov.: 31 AF XY: 0.000111 AC XY: 81AN XY: 727208
GnomAD4 genome AF: 0.0000656 AC: 10AN: 152348Hom.: 0 Cov.: 33 AF XY: 0.0000537 AC XY: 4AN XY: 74490
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 25, 2024 | The c.2082A>T (p.E694D) alteration is located in exon 22 (coding exon 20) of the NEK5 gene. This alteration results from a A to T substitution at nucleotide position 2082, causing the glutamic acid (E) at amino acid position 694 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at